Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Wire to Wire Daily Stock Picking -- Ignore unavailable to you. Want to Upgrade?

To: wbASSETt who wrote (2054)	7/21/1999 3:53:00 PM
From: Jeffrey L. Henken	Read Replies (3) \| Respond to of 3514

WASP Due Diligence: Float: 5.1 Million shares Outstanding: 17 Million shares Wasatch Pharmaceutical has been in business since 1986. They currently have two clinics in Utah. They will be filing for FDA approval for applications in a number of over the counter drugs for skin care. Diseases that they have cures for in skin care: Acne, Psoriasis and Eczema. The management team is focused on research and development of other products. Over 2000 clinical studies have been performed and published. Success rate is far above any others in the marketplace with less side effects. Currently have skin rejuvenation product that actually rebuilds skin cells. The market for the above is 10 billion a year.